Real-world study demonstrates importance of asthma device choice

Amy Schofield 15 February 2018

A real-world study in more than 18,000 patients has demonstrated superior asthma control with the AeroChamber Plus* Flow-Vu* Anti-Static Valved Holding Chamber (VHC) compared with other chambers.

According to this new retrospective study, published in Pulmonary Therapy, the AeroChamber Plus* Flow-Vu* Anti-Static VHC was associated with a significant delay in time to first exacerbation (p=0.0005) and a significant 13% reduction in Emergency Room/Accident and Emergency visits (p=0.0167) compared with control, non-anti-static chambers.

There was also a strong trend towards a reduction in hospitalisations (p=0.0702). The AeroChamber Plus* Flow-Vu* Anti-Static VHC was made available on prescription in the UK in November 2017.

The AeroChamber Plus* Flow-Vu* Anti-Static VHC is designed with user-friendly features to improve patients’ inhaler technique and to ensure delivery of the intended dose of medication, leading to clinical benefits for patients. The chamber is made from an antistatic polymer which prevents electrostatic charge-related loss of medication to the walls of the chamber and allows it to be used straight out of the packet without pre-treatment or priming.

This device has a dedicated inhalation indicator (branded as the Flow-Vu* Inhalation Indicator). This feedback tool gives caregivers the ability to confirm that there is a proper facemask seal, which helps the caregiver to coordinate actuation of the pressurised metered-dose inhaler (pMDI) with inhalation and to count breaths, thus ensuring the patient gets the intended dose of their prescribed medications.

Dr Alan Clark, Regional Head, Europe, Trudell Medical UK Ltd, said: “We aim to bring innovative solutions to real-life problems, unlocking improved outcomes for respiratory patients."

Dr Dermot Ryan, President of the Respiratory Effectiveness Group and former primary care physician, said: “It’s great to see a company take a very good product and make it even better by putting the patient at the centre of the development process and using their feedback to make it easier to use."


Make a comment

To voice your opinion, please Log in or Register.

Pf Magazine

Your resource for news, features, interviews, careers and events in the pharma industry.

Click here for the latest issue and to subscribe.